For citations:
Astakhov Yu.S., Rukhovets A.G., Nechiporenko P.A., Novikov D.P., Sarantseva N.V., Kuznetsova E.S., Petunov V.S., Rybina M.V., Kharlamov G.V., Koshkina N.O., Meshviliani E.V., Alchinova A.S., Stavitskaya O.A. Results of a multicenter comparative study of the efficacy and safety of therapy with 0.03% bimatoprost and 0.004% travoprost. National Journal glaucoma. 2021;20(1):32-37. (In Russ.) https://doi.org/10.25700/NJG.2021.01.04
Email this article 